Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human NOSTRIN ELISA Kit (AC3318)
Cat.#: ASET-1907
Specifications
Description Human NOSTRIN ELISA Kit allows for the in vitro quantitative determination of human NOSTRIN concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2023 Human PAX8 ELISA Kit (AC3434) Quantitative inquiry ASET-2229 Mouse GABA ELISA Kit (AC3640) Quantitative inquiry ASET-1197 Human EMP3 ELISA Kit (AC2608) Quantitative inquiry ASET-1402 Human Nicotinic Acetylcholine Receptor alpha 7 ELISA Kit (AC2813) Quantitative inquiry ASET-1029 Human APLP2 ELISA Kit (AC2440) Quantitative inquiry ASET-2069 Mouse Neurotensin ELISA Kit (AC3480) Quantitative inquiry ASET-1367 Porcine Syndecan-1 ELISA Kit (AC2778) Quantitative inquiry ASET-2422 Human SHARP1 ELISA Kit (AC3833) Quantitative inquiry ASET-1460 Mouse VGLUT2 ELISA Kit (AC2871) Quantitative inquiry ASET-1809 Human Ephrin B2 ELISA Kit (AC3220) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket